Cargando…
Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review
In the clinical setting of renal cell carcinoma (RCC), immune reactions such as tumor-specific T cell responses can be spontaneous events or can be elicited by checkpoint inhibitors, cytokines, and other immunotherapy modalities. The results from immunotherapy have led to significant advances in tre...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Urological Association
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448669/ https://www.ncbi.nlm.nih.gov/pubmed/36067994 http://dx.doi.org/10.4111/icu.20220103 |